Anuh Pharma standalone net profit rises 892.22% in the March 2022 quarter

Anuh Pharma standalone net profit rises 78.23% in the December 2021 quarter

Anuh Pharma Standalone September 2021 Net Sales At Rs 108.74 Crore, Down 3.11% Y-o-Y

Anuh Pharma standalone net profit rises 29.52% in the September 2021 quarter

Anuh Pharma standalone net profit declines 66.57% in the June 2021 quarter

Anuh Pharma reports standalone net profit of Rs 0.90 crore in the March 2021 quarter

Anuh Pharma standalone net profit declines 34.07% in the December 2020 quarter

Board of Anuh Pharma approves change in directorate

The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.

BRIEF-Anuh Pharma MD Bipin Shah Resigns - Investing.com India

BRIEF-Anuh Pharma Names Ritesh B. Shah, Vivek B. Shah As Joint Managing Directors - Investing.com India

BRIEF-India’s Anuh Pharma Posts March-Qtr Loss After Tax - Investing.com India

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced and in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Not a good time to consider, stock is in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Anuh Pharma Limited is engaged in the manufacturing of pharmaceuticals, medicinal, chemical and botanical products. The Company manufactures active pharmaceutical ingredients (APIs). It also sells bulk drugs and chemicals.

Anuh Pharma Ltd